|
Powered by Cell Signaling Technology |
Site Information |
---|
EELSsQMssFNEAMT SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 5829783 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Kinases, in vitro: |
Downstream Regulation | |
---|---|
Effects of modification on KIF2C: | |
Effects of modification on biological processes: |
References | |
---|---|
Ritter A, et al. (2015) The activity regulation of the mitotic centromere-associated kinesin by Polo-like kinase 1. Oncotarget 6, 6641-55
25504441 Curated Info |
|
Ruse CI, et al. (2008) Motif-specific sampling of phosphoproteomes. J Proteome Res 7, 2140-50
18452278 Curated Info |
|
Possemato A (2007) CST Curation Set: 2647; Year: 2007; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-(Ser/Thr) PKD Substrate Antibody Cat#: 4381, PTMScan(R) Phospho-PKD Substrate Motif (LXRXXpS/pT) Immunoaffinity Beads Cat#: 1986
Curated Info |